Project
EORTC 1901-LCG PRIMALung Study
Scheduled · 2022 until 2030
Putora Paul Martin, Glatzer Markus, Dennstädt Fabio
Type
Clinical Studies
Range
Multicentric, KSSG as participating partner
Units
Status
Scheduled
Start Date
2022
End Date
2030
Financing
Others
Study Design
This is an academic-led, open-label, multicentre, randomized phase III trial.
Labels
lung cancer
Brief description/objective
PRophylactic cerebral Irradiation or active MAgnetic resonance imaging surveillance in small-cell Lung cancer patients (PRIMALung study)